Topotarget Company Profile

Aggregated data from the web about Topotarget

Company Name	Topotarget
Website	https://en.wikipedia.org
Snippet	TopoTarget (Nasdaq Copenhagen: TOPO) was a Copenhagen-based biotechnology company focused on the discovery and development of drugs and therapies to treat cancer.In 2014, it merged with BioAlliance Pharma and is now part of Onxeo.. It was founded in 2000 by a group of clinicians. TopoTarget was involved in collaborations with both academia and industry.
Type	Public (Nasdaq Copenhagen: TOPO)
Founded	2000
Revenue	DKK 43.979 million (2009)[2], p. 24
Website	http://www.topotarget.com/
Industry	Biotechnology
Key people	Francois Martelet(Chief Executive Officer)[1]Anders Fink Vadsholt(CFO & Head of IR)[1]Bo Jesper Hansen(Chairman of the Board)[1]Peter Buhl Jensen(co-foundar)Jean-Louis Misset (Global Medical and Scientific Advisory Board)[1]
Net income	DKK 140.46 million (2009)[2], p. 24
Headquarters	Copenhagen, Denmark
Total assets	DKK 585.41 million (2009)[2], p. 24
Total equity	DKK 411.79 million (2009)[2], p. 24
Operating income	DKK 132.49 million (2009)[2], p. 24
Number of employees	53 (2009)[2], pp. 24; 68 (2008)[3], p. 36;

Topotarget is part of the Denmark company list

Topotarget is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.